Nir Naor
Direttore Finanziario/CFO presso AXOGEN, INC.
Patrimonio netto: 2 M $ in data 31/05/2024
Profilo
Nir Naor is an Independent Director at Brainstorm Cell Therapeutics, Inc. and the Chief Financial Officer at Axogen, Inc. He previously worked as an Auditor at KPMG Corporate Finance LLC from 2001 to 2005.
From 2012 to 2017, he served as the Chief Financial Officer-United States at UCB SA. He also held the position of Chief Financial Officer at Arbor Pharmaceuticals, Inc. in 2021 and Chief Financial Officer-US Americas at Molnlycke Health Care US LLC from 2017 to 2021.
Additionally, he was the Chief Financial Officer at QuVa Pharma, Inc. in 2023 and Hmnc Brain Health GmbH from 2021 to 2022.
Mr. Naor obtained his undergraduate and graduate degrees from Tel-Aviv University, and he holds an MBA from the International Institute for Management Development.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
AXOGEN, INC.
0.69% | 01/01/2024 | 300 000 ( 0.69% ) | 2 M $ | 31/05/2024 |
| 19/06/2023 | 11 999 ( 0.02% ) | 5 844 $ | 31/05/2024 |
Posizioni attive di Nir Naor
| Società | Posizione | Inizio |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Direttore/Membro del Consiglio | 20/06/2023 |
| AXOGEN, INC. | Direttore Finanziario/CFO | 06/12/2023 |
Precedenti posizioni note di Nir Naor
| Società | Posizione | Fine |
|---|---|---|
QuVa Pharma, Inc.
 QuVa Pharma, Inc. Pharmaceuticals: MajorHealth Technology QuVa Pharma, Inc. provides sterile compounding pharmacy services. It develops, manufactures and distributes compounded sterile preparations. The firm provides vital compounded medications for obstetrics, OR, anesthesia, general medicine, cardiovascular, ER, and pain management. The company was founded by Stuart Hinchen and Peter Linsay Jenkins in 2015 and is headquartered in Austin, TX. | Direttore Finanziario/CFO | 01/09/2023 |
Hmnc Brain Health GmbH
 Hmnc Brain Health GmbH Medical SpecialtiesHealth Technology Hmnc Brain Health GmbH is a precision psychiatry biopharma German company that develops personalized therapies for major depressive disorder and treatment-resistant depression. The company is headquartered in Germany and has a presence in both Europe and the United States. Hmnc Brain Health is backed by a renowned VC, several family offices, and a strategic healthcare investor. The CEO of the private company is Benedikt von Braunmühl. | Direttore Finanziario/CFO | 01/10/2022 |
Arbor Pharmaceuticals, Inc.
 Arbor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, Inc. develops pharmaceutical products with a focus on cardiovascular, hospital, and pediatric markets. The company is based in Atlanta, GA. Edward J. Schutter has been the CEO of the company since 2010. | Direttore Finanziario/CFO | 01/09/2021 |
Molnlycke Health Care US LLC
 Molnlycke Health Care US LLC Medical SpecialtiesHealth Technology Molnlycke Health Care U.S. LLC manufactures surgical and wound care products. It offers drapes, procedure trays, surgical powder free gloves, and skin antiseptics. The firm's brands include Biogel, Mepilex, Mepitel, Mepore, Tubigrip, and Xelma. The company is headquartered in Norcross, GA | Corporate Officer/Principal | 01/01/2021 |
| UCB | Corporate Officer/Principal | 01/09/2017 |
Formazione di Nir Naor
| International Institute for Management Development | Masters Business Admin |
| University of Hamburg | Graduate Degree |
| Tel-Aviv University | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| AXOGEN, INC. | Health Technology |
| UCB | Health Technology |
| Aziende private | 5 |
|---|---|
Arbor Pharmaceuticals, Inc.
Arbor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, Inc. develops pharmaceutical products with a focus on cardiovascular, hospital, and pediatric markets. The company is based in Atlanta, GA. Edward J. Schutter has been the CEO of the company since 2010. | Health Technology |
Molnlycke Health Care US LLC
Molnlycke Health Care US LLC Medical SpecialtiesHealth Technology Molnlycke Health Care U.S. LLC manufactures surgical and wound care products. It offers drapes, procedure trays, surgical powder free gloves, and skin antiseptics. The firm's brands include Biogel, Mepilex, Mepitel, Mepore, Tubigrip, and Xelma. The company is headquartered in Norcross, GA | Health Technology |
KPMG Corporate Finance LLC
 KPMG Corporate Finance LLC Investment ManagersFinance KPMG Corporate Finance LLC provides investment advisory services. The firm offers mergers and acquisitions advisory services including buy side, sell side, equity and debt financings and management buyouts. The company is headquartered in Chicago, IL. | Finance |
QuVa Pharma, Inc.
QuVa Pharma, Inc. Pharmaceuticals: MajorHealth Technology QuVa Pharma, Inc. provides sterile compounding pharmacy services. It develops, manufactures and distributes compounded sterile preparations. The firm provides vital compounded medications for obstetrics, OR, anesthesia, general medicine, cardiovascular, ER, and pain management. The company was founded by Stuart Hinchen and Peter Linsay Jenkins in 2015 and is headquartered in Austin, TX. | Health Technology |
Hmnc Brain Health GmbH
Hmnc Brain Health GmbH Medical SpecialtiesHealth Technology Hmnc Brain Health GmbH is a precision psychiatry biopharma German company that develops personalized therapies for major depressive disorder and treatment-resistant depression. The company is headquartered in Germany and has a presence in both Europe and the United States. Hmnc Brain Health is backed by a renowned VC, several family offices, and a strategic healthcare investor. The CEO of the private company is Benedikt von Braunmühl. | Health Technology |
- Borsa valori
- Insiders
- Nir Naor
